Stock NNVC NANOVIRICIDES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions NanoViricides, Inc.

Equities

NNVC

US6300873022

Delayed Nyse
Other stock markets
 11:16:57 2024-05-01 am EDT 		5-day change 1st Jan Change
1.21 USD +0.83% Intraday chart for NanoViricides, Inc. +5.22% +18.63%
Apr. 30 NanoViricides, Inc. Reports That the Phase I NV-387 Clinical Trial Is Completed Successfully and Data Lock Is Expected Soon CI
Feb. 14 NanoViricides, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. NNVC Stock
  4. Revisions NanoViricides, Inc.